Form4insider filings, from the source

SEC Form 4 · accession 0001144204-17-006290

CALADRIUS BIOSCIENCES, INC. · CLBS

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Eric Wei
Director
Period of report
Feb 2, 2017
Accepted (ET)
Feb 6, 2017 · 7:47 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000320017

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2,F3Feb 2, 2017S5,000$4.5094D182,223ISee Footnote
Common StockF1,F2,F3Feb 2, 2017S1,400$4.7507D180,823ISee Footnote
Common StockF1,F2,F3Feb 3, 2017S1,525$4.7582D179,298ISee Footnote
Common StockF1,F2,F3Feb 6, 2017S500$4.75D178,798ISee Footnote
Common StockF4holding———4,300D

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses